Niloy Samadder
Enterprise Co-Leader, Mayo Clinic Comprehensive Cancer Center, Cancer Individualized Medicine, Mayo Clinic Comprehensive Cancer Center · Mayo Clinic College of Medicine and Science
Credentials: · · · · · ·
History
PresentMayo Clinic Comprehensive Cancer Center · Mayo Clinic College of Medicine and Science
- Present
Department of Internal Medicine · Mayo Clinic College of Medicine and Science
- 2009–2012
Gastroenterology University of Michigan
- 2006–2009
- 2003–2006
Internal Medicine University of Toronto
- 1999–2003
Research
JAMA Oncology · 2021 · First of 28 authors · 255 citations
Gastroenterology · 2014 · First of 12 authors · Corresponding · 242 citations
Systematic review or meta-analysis · The American Journal of Gastroenterology · 2014 · Last of 5 authors · 224 citations
- RB
30 papers
- EE
15 papers
13 papers
11 papers
11 papers · 10 as a resident
11 papers
8 papers
- RP
8 papers
Grants
- 2018–2030
- 2013–2028
Colon Cancer Family Registry Cohort
National Cancer Institute · U01
PI · $5.2M · University of Melbourne
- 2017–2020
Metabolomic Strategies to Identify Biomarkers of Chemoprevention in FAP Patients
National Cancer Institute · R21
PI · $402.7K · Utah State Higher Education System--University of Utah
Clinical trials
- 2026–2027
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
- 2022–2027
Principal investigator · Recruiting
Mayo Clinic
- 2021–2031
Economic and Clinical Outcomes of (Whole Exome) Sequencing in Tapestry
Principal investigator · Enrolling by invitation
Mayo Clinic
- 2021–2022
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
Principal investigator · Terminated
National Cancer Institute (NCI)